Vireo Growth VREOF
OTC VREOF
$10.97 -0.01 (-0.09%)
At close: Aug 19, 2026 · 3:35 PM UTC

Vireo Growth (VREOF) Shares Outstanding (2020 - 2026)

Vireo Growth (VREOF) posted Shares Outstanding (Entity) of $1.1 billion for Q1 2026, up 43.89% sequentially from $734.7 million in Q4 2025, and up 211.42% YoY from $339.5 million in Q1 2025.

Vireo Growth (VREOF) Shares Outstanding (2020 - 2026) Analysis & Trends

Vireo Growth has reported Shares Outstanding (Entity) for 7 years, with the latest figure at $1.1 billion in Q1 2026.

  • Quarterly Shares Outstanding (Entity) rose 211.42% year-over-year to $1.1 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.1 billion (up 211.42% YoY) and the FY2025 annual result came in at $734.7 million, up 307.3% from the prior year.
  • Shares Outstanding (Entity) advanced to $1.1 billion in Q1 2026 per VREOF's latest filing, from $734.7 million in the prior quarter.
  • Over five years, Shares Outstanding (Entity) peaked at $1.1 billion in Q1 2026 and troughed at $110.0 million in Q4 2023.
  • A 5-year average of $311.9 million and a median of $143.1 million in 2024 frame the typical range for Shares Outstanding (Entity).
  • The sharpest annual moves came in 2023 and 2025: Shares Outstanding (Entity) decreased 14.14% in 2023, then surged 360.88% in 2025.
  • Over 5 years, Shares Outstanding (Entity) stood at $128.1 million in 2022, then slipped by 14.14% to $110.0 million in 2023, then jumped by 63.98% to $180.4 million in 2024, then soared by 307.3% to $734.7 million in 2025, then surged by 43.89% to $1.1 billion in 2026.
  • According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $1.1 billion, $734.7 million, and $923.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Shares Outstanding (Qtr)
1 Haleon 43.76 Bn 42.80 Bn - 4.44 Bn
2 Teva Pharmaceutical Industries 43.05 Bn 39.39 Bn 2.15 Bn 1.17 Bn
3 Zoetis 31.51 Bn 29.84 Bn 1.05 Bn 417.60 Mn
4 Takeda Pharmaceutical 28.70 Bn 22.90 Bn 5.10 Bn 1.58 Bn
5 United Therapeutics 22.27 Bn 19.61 Bn 683.80 Mn 42.60 Mn
6 Viatris 18.83 Bn 17.95 Bn 1.46 Bn 1.16 Bn
7 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 101.00 Mn
8 Elanco Animal Health 12.06 Bn 11.53 Bn 798.00 Mn 499.50 Mn
9 Dr Reddys Laboratories 10.12 Bn 9.95 Bn - 832.44 Mn
10 Vireo Growth 493.25 Mn 350.95 Mn 95.30 Mn 45.09 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 1.08 Bn
Dec 31, 2025 734.74 Mn
Sep 30, 2025 949.82 Mn
Jun 30, 2025 559.10 Mn
Mar 31, 2025 366.80 Mn
Dec 31, 2024 180.39 Mn
Sep 30, 2024 201.38 Mn
Jun 30, 2024 143.58 Mn
Mar 31, 2024 143.13 Mn
Dec 31, 2023 135.24 Mn
Sep 30, 2023 141.33 Mn
Jun 30, 2023 128.13 Mn
Mar 31, 2023 128.13 Mn
Dec 31, 2022 128.13 Mn
Sep 30, 2022 128.12 Mn
Jun 30, 2022 128.11 Mn
Mar 31, 2022 128.11 Mn
Dec 31, 2021 123.81 Mn
Sep 30, 2021 126.36 Mn
Jun 30, 2021 125.56 Mn